Abstract:Circulatory changes with increased blood flow and vasodilatation/vasoconstriction imbalance are an integral consequence of liver cirrhosis and portal hypertension and can affect the pulmonary circulation with the development of vascular disorders, with hepatopulmonary syndrome (HPS) being the most common. HPS is a serious pulmonary complication of progressive liver disease, resulting in a poor clinical prognosis. Vascular tone decrease, monocytic infiltration of pulmonary vessels, formation of intrapulmonary arteriovenous shunts, dysfunction of alveolar type II cells, destruction of the endothelial glycocalyx are important in the pathogenesis of HPS. Abnormalities of pulmonary capillaries lead to hypoxemia caused by a violation of the ventilation/perfusion ratio, diffusion disorders, and the development of arteriovenous anastomoses. Infiltration of the pulmonary vessels by monocytes is one of the key factors of HPS. This migration is facilitated by the intestinal microbiota translocation into the portal bloodstream with increased expression of proinflammatory cytokines (tumor necrosis factor α, interleukins 1, 6), leading to the activation of monocytes. Monocytes located in the pulmonary circulation promote the vasodilation through the activation of inducible nitric oxide (NO) synthase and thus NO production. This is also associated with endothelial dysfunction due to a decreased hepatic secretion of bone morphogenetic protein 9 and increased endothelin 1, endothelial overexpression of endothelin B receptors, and increased endothelial NO production. Proangiogenic factors such as vascular endothelial growth factor, platelet-derived growth factor, and placental growth factor play an important role in the proliferation of pulmonary capillaries. Circulation of tumor necrosis factor α, bile acids and monocyte infiltration in the pulmonary circulation lead to increased apoptosis of alveolar type II cells and decreased surfactant synthesis. Chronic inflammation in HPS disrupts the continuity of the endothelial glycocalyx layer. This article provides an overview of the current knowledge on the pathogenesis of HPS, summarizes many features of the disease based on the literature research in MEDLINE database on the PubMed platform.

Progress in investigating the pathogenesis of hepatopulmonary syndrome.

Pathophysiological basis of hepatopulmonary syndrome

Hepatopulmonary Syndrome: the Role of Intra-Abdominal Hypertension and A Novel Mouse Model

Hepatopulmonary Syndrome: A Comprehensive Review

Diagnosis and management of hepatopulmonary syndrome

Role of vascular mediators in the pathogenesis of hepatopulmonary syndrome in rats

[Significance of Lipopolysaccharides, Toll-Like Receptor and Inducible Nitric Oxide Synthase in Hepatopulmonary Syndrome].

Hepatopulmonary Disorders: Gas Exchange and Vascular Manifestations in Chronic Liver Disease.

Hepatopulmonary Syndrome and Portopulmonary Hypertension: Current Status and Implications for Liver Transplantation

[Lung Expression of Tissue Factor Mrna and Its Significance in a Rat Model of Hepatopulmonary Syndrome].

Pathogenesis and Therapy of Hermansky–Pudlak Syndrome (HPS)-Associated Pulmonary Fibrosis

The complex interrelationships between chronic lung and liver disease: a review

Endothelial glycocalyx in hepatopulmonary syndrome: An indispensable player mediating vascular changes

Multiple Pathogenic Factor-Induced Complications of Cirrhosis in Rats: A New Model of Hepatopulmonary Syndrome with Intestinal Endotoxemia

Oxidative stress as one of the pathogenetic mechanisms of hepatopulmonary syndrome in patients with liver cirrhosis

Advances in the research of sulfur dioxide and pulmonary hypertension

Changes of serum cytokines and pulmonary intravascular macrophages in rats with hepatopulmonary syndrome

Serum Soluble Vascular Endothelial Growth Factor Receptor 1 As a Potential Biomarker of Hepatopulmonary Syndrome.

Inflammation and immunity in the pathogenesis of hypoxic pulmonary hypertension

Research Advances in the Pathogenesis of Multiple Organ Dysfunction Syndrome in Patients with Liver Cirrhosis and Related Treatment Regimens

The association of lipopolysaccharide and inflammatory factors with hepatopulmonary syndrome and their changes after orthotopic liver transplantation.